Protega Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PROTEGA PHARMS, and when can generic versions of PROTEGA PHARMS drugs launch?
PROTEGA PHARMS has one approved drug.
There are two US patents protecting PROTEGA PHARMS drugs.
There are twenty-two patent family members on PROTEGA PHARMS drugs in ten countries and one supplementary protection certificate in one country.
Summary for Protega Pharms
| International Patents: | 22 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Protega Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-004 | Sep 5, 2024 | RX | No | No | 7,955,619 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-002 | Apr 20, 2017 | RX | No | No | 10,314,788 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-001 | Apr 20, 2017 | RX | No | No | 10,314,788 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-004 | Sep 5, 2024 | RX | No | No | 10,314,788 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-001 | Apr 20, 2017 | RX | No | No | 7,955,619 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Protega Pharms | ROXYBOND | oxycodone hydrochloride | TABLET;ORAL | 209777-003 | Apr 20, 2017 | RX | No | No | 10,314,788 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Protega Pharms Drugs
Supplementary Protection Certificates for Protega Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1685839 | 92292 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
